dc.contributor.author | Allen, Claire | |
dc.date.accessioned | 2020-03-24T12:57:46Z | |
dc.date.available | 2020-03-24T12:57:46Z | |
dc.date.issued | 2020-03-19 | |
dc.identifier.uri | https://www.evidenceaid.org/chinese-herbs-combined-with-western-medicine-in-the-treatment-of-severe-acute-respiratory-syndrome-sars/ | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12663/769 | |
dc.description.abstract | What is this? The first cases of severe acute respiratory syndrome (SARS) were reported in December 2002. This is an acute respiratory disease caused by a coronavirus and integrated Chinese and Western medicines may have played a role in its successful treatment. Therefore, evidence from studies of these treatments of SARS might help in identifying treatments for COVID-19. In this Cochrane systematic review, the authors searched for randomized and quasi-randomized trials of Chinese herbs combined with Western medicines versus Western medicines alone for patients with SARS. They did not restrict by language of publication and did their searches in March 2012. They identified 12 randomized and one quasi-randomized trial (total: 640 patients), evaluating 12 different Chinese herbs. | en_US |
dc.language | English | en_US |
dc.subject | Severe Acute Respiratory Syndrome (SARS) | en_US |
dc.subject | Infectious Diseases | en_US |
dc.subject | Medicine, Chinese Tradittional | en_US |
dc.title | Chinese herbs combined with Western medicine in the treatment of severe acute respiratory syndrome (SARS) | en_US |
eihealth.country | Others | en_US |
eihealth.category | Clinical characterization and management | en_US |
eihealth.type | Published Article | en_US |
eihealth.maincategory | Slow Spread / Reducir la Dispersión | en_US |
dc.relation.ispartofjournal | Evidence Aid | en_US |